Dr William Schaffner discusses strategies clinicians can use to address vaccine hesitancy, fatigue, and misinformation.

Researchers conducted a network meta-analysis to compare the efficacy of various oral antibiotic monotherapies for ...

Researchers evaluated the immunogenicity of the MenACWY-TT vaccine against hypervirulent serogroup Y meningococcal strains in ...

Investigators evaluated HPV vaccine initiation at ages 9 to 10 years vs 11 to 12 years across pediatric practices in Colorado ...

Researchers evaluated household contact transmission risks and vaccination timing among children younger than 5 years.

Research presented at CHEST 2026 highlights the role of rapid antimicrobial testing and antibiotic stewardship in patients ...

Researchers evaluated the association between maternal COVID-19 infection during pregnancy and subsequent neurologic ...

The updated vaccines are expected to be available in pharmacies, hospitals, and clinics in the coming days. In May 2026, the FDA’s Vaccines and Related Biological Products Advisory Committee ...

The AAP continues to recommend RSV immunization for all eligible infants younger than 8 months entering their first RSV season. The American Academy of Pediatrics (AAP) has issued updated ...

MMR vaccination coverage among US kindergartners dropped as national nonmedical exemptions rose. HealthDay News — A record share of U.S. kindergartners started school last year without at least one ...

The US Senate has confirmed Dr Erica Schwartz as the new director of the CDC, tasking her with navigating active public health crises and addressing growing skepticism with routine immunizations.

The mRNA-based influenza vaccine is expected to be available in the coming weeks. The Food and Drug Administration (FDA) has approved mFlusiva ®, the first mRNA-based influenza vaccine, for adults ...